The latest price in 2024: Economic guide to the administration of avatrombopag!

Avatrombopag (Avatrombopag) is a medicine used to treat certain types of thrombocytopenia. It belongs to a class of drugs called thrombopoietin receptor agonists, which work by stimulating the bone marrow to produce more platelets, thereby increasing platelet levels.

Avatrombopag is now available in China and has been included in the medical insurance system, so patients can purchase it directly in China. Its selling price is approximately in the range of three to four thousand yuan. For detailed price information and specific proportions of medical insurance reimbursement, patients are advised to consult the pharmacy of their local hospital for accurate information. In addition, there are more affordable generics of avatrombopag on the foreign market, mainly in Laos and Bangladesh. The price of these generic drugs ranges from a few hundred to a thousand yuan, and their ingredients are basically the same as the original drugs.

This medication is usually used to treat certain types of thrombocytopenia in people with chronic liver disease, such as chronic immune thrombocytopenia (ITP) due to cirrhosis. In this case, impaired liver function can lead to a decrease in platelet counts, which increases the risk of bleeding.

Avatrombopag promotes the proliferation and differentiation of megakaryocytes in the bone marrow by binding to the thrombopoietin receptor and activating its signaling pathway, thereby increasing the production of platelets. This can help increase a patient's platelet levels and reduce or prevent bleeding events.

However, caution is required when using avatrombopag as it may cause side effects such as headache, nausea, fatigue, etc., and there may be additional risks for patients with severe liver disease. Therefore, doctors will weigh the pros and cons based on the patient's specific situation to determine whether this drug is suitable for use, and monitor responses and side effects during treatment.